Obermayr Franz 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Obermayr Franz
Acting CEO
Transactions
- Award
Stock Option (right to buy)
2021-02-01+30,000→ 30,000 totalExercise: $6.46Exp: 2031-02-01→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2022, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.